Debt-to-equity of TEVA PHARMACEUTICAL INDUSTRIES LTD from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly Debt-to-equity in % history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD Debt-to-equity for the quarter ending 30 Sep 2025 was 512%, a 1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 512% -5% -1% 30 Sep 2025
Q2 2025 548% +49% +9.8% 30 Jun 2025
Q1 2025 565% +75% +15% 31 Mar 2025
Q4 2024 554% +75% +16% 31 Dec 2024
Q3 2024 517% +43% +9.1% 30 Sep 2024
Q2 2024 499% +52% +12% 30 Jun 2024
Q1 2024 489% +67% +16% 31 Mar 2024
Q4 2023 479% +69% +17% 31 Dec 2023
Q3 2023 474% +89% +23% 30 Sep 2023
Q2 2023 447% +74% +20% 30 Jun 2023
Q1 2023 422% +57% +16% 31 Mar 2023
Q4 2022 409% +47% +13% 31 Dec 2022
Q3 2022 385% +13% +3.5% 30 Sep 2022
Q2 2022 372% -15% -3.8% 30 Jun 2022
Q1 2022 365% +4% +1.1% 31 Mar 2022
Q4 2021 362% +23% +6.6% 31 Dec 2021
Q3 2021 372% +53% +17% 30 Sep 2021
Q2 2021 387% +87% +29% 30 Jun 2021
Q1 2021 361% +55% +18% 31 Mar 2021
Q4 2020 340% +34% +11% 31 Dec 2020
Q3 2020 319% +13% +4.3% 30 Sep 2020
Q2 2020 300% +8% +2.8% 30 Jun 2020
Q1 2020 306% +26% +9.2% 31 Mar 2020
Q4 2019 305% +34% +12% 31 Dec 2019
Q3 2019 306% +34% +13% 30 Sep 2019
Q2 2019 292% +45% +18% 30 Jun 2019
Q1 2019 280% +50% +22% 31 Mar 2019
Q4 2018 272% +68% +34% 31 Dec 2018
Q3 2018 272% +89% +49% 30 Sep 2018
Q2 2018 247% +70% +39% 30 Jun 2018
Q1 2018 230% +79% +52% 31 Mar 2018
Q4 2017 204% +72% +54% 31 Dec 2017
Q3 2017 182% +74% +68% 30 Sep 2017
Q2 2017 178% +89% +100% 30 Jun 2017
Q1 2017 152% +56% +58% 31 Mar 2017
Q4 2016 132% +28% +27% 31 Dec 2016
Q3 2016 109% -1% -0.6% 30 Sep 2016
Q2 2016 89% -17% -16% 30 Jun 2016
Q1 2016 96% -4% -4.2% 31 Mar 2016
Q4 2015 103% +4% +4% 31 Dec 2015
Q3 2015 109% +7% +7% 30 Sep 2015
Q2 2015 105% -1% -1.1% 30 Jun 2015
Q1 2015 100% -12% -10% 31 Mar 2015
Q4 2014 100% -14% -13% 31 Dec 2014
Q3 2014 102% -15% -12% 30 Sep 2014
Q2 2014 107% -11% -9.1% 30 Jun 2014
Q1 2014 112% -4% -3.2% 31 Mar 2014
Q4 2013 114% -4% -3.1% 31 Dec 2013
Q3 2013 117% -1% -1.2% 30 Sep 2013
Q2 2013 117% +8% +7.1% 30 Jun 2013
Q1 2013 116% +18% +18% 31 Mar 2013
Q4 2012 117% +32% +37% 31 Dec 2012
Q3 2012 118% +45% +62% 30 Sep 2012
Q2 2012 109% +36% +50% 30 Jun 2012
Q1 2012 98% +22% +29% 31 Mar 2012
Q4 2011 86% +9% +11% 31 Dec 2011
Q3 2011 73% 30 Sep 2011
Q2 2011 73% 30 Jun 2011
Q1 2011 76% 31 Mar 2011
Q4 2010 77% 31 Dec 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.